Pharma Pricing Policy

The Department of Pharmaceuticals on Thursday notified Drug Price Control Order 2013. Once implemented over next few months, prices of 348 essential drugs will come down. Market reaction was mixed with firms like Cipla, Sun Pharma, Ranbaxy, Lupin and Glenmark down 0.5-2%.

Pharma body challenges government‘s method of pricing

The government wants more time to table its new drug pricing norms. The Supreme Court has deferred hearing the matter till the 12th of December. Meanwhile, the pharma pricing policy has been challenged by the All India Drug Action Network (AIDAN).

Pharma pricing policy is bitter pill for biz, public: Shah

DG Shah, secretary-general, Indian Pharmaceutical Alliance explains to CNBC-TV18 that the new pharma pricing adopted by the government would offer less effective drugs to consumers, stifle the growth of research and development in India and stall overseas investment.

Will take pharma GoM reccos before Cabinet by Nov 27: Pawar

The Group of Ministers (GoM), headed by agriculture minister Sharad Pawar, meeting on pharma pricing policy concluded today with the minister saying all differences have been resolved. CNBC-TV18's Rituparna Bhuyan reports.

Govt to SC: Cabinet may take up pharma policy on Nov 15

The pharma pricing policy is now moving faster as the Supreme Court keeps a close watch.

Bringing essential drugs under control a fair policy:CII

The proposal to bring 348 essential drugs under government control recommends a shift from cost-based to market-based pricing which will help improve the availability of such medicines, CII said today.

Pharma policy to impact cos; buy Lupin, Cipla: Edelweiss

Manoj Garg of Edelweiss Securities believes it is a balanced policy and will help to reduce prices by about 15-20 percent. In some cases, it might even be lowered by as much as 40-50 percent.

Pharma GoM submits pricing proposal to Cabinet

CNBC-TV18 has learnt that in another key meeting on Thursday, the group of ministers (GoM) formed to decide the new pharma pricing policy has finalised a proposal to set the price-ceiling on pharmaceutical drugs.